Search research articles
Contact Us
Filters
Showing results (51-60 of 102) with videos related to
Page
of 11
Sort By:
Angewandte Chemie (International Ed. in English)
|
October 31, 2002
Silynes (RC identical with SiR') and Disilynes (RSi identical with SiR'): Why Are Less Bonds Worth Energetically More? The research is supported by an Israel Science Foundation (ISF) and a Niedersachsen grant (to S.S.), by a U.S.-Israel Binational Science Foundation (BSF) grant (to Y.A.) and by the Minerva Foundation. S.S. and F.O. thank the European Union for a Marie Curie Fellowship (Contract number: MCFI-1999-00145). S.S. and D.D. thank P. C. Hiberty for the helpful advice
David Danovich, François Ogliaro, Miriam Karni, et al.
Research and Practice in Thrombosis and Haemostasis
|
September 1, 2020
Hemophilia without prophylaxis: Assessment of joint range of motion and factor activity
Michael Wang, Michael Recht, Neeraj N Iyer, et al.
Angewandte Chemie (International Ed. in English)
|
May 2, 2018
Silynes (RC≡SiR') and Disilynes (RSi≡SiR'): Why Are Less Bonds Worth Energetically More?
David Danovich, François Ogliaro, Miriam Karni, et al.
Pediatric Blood & Cancer
|
May 28, 2016
Safety and efficacy of recombinant factor VIIa by pediatric age cohort: reassessment of compassionate use and trial data supporting US label
Stacy E Croteau, Charles Nakar, Ellis J Neufeld, et al.
Patient Preference and Adherence
|
September 2, 2017
Construct validity of patient-reported outcome instruments in US adults with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study
Katharine Batt, Michael Recht, David L Cooper, et al.
Patient Related Outcome Measures
|
September 10, 2019
Mild-severe hemophilia B impacts relationships of US adults and children with hemophilia B and their families: results from the B-HERO-S study
Susan Cutter, Christine Guelcher, Susan Hunter, et al.
Journal of Blood Medicine
|
September 28, 2020
Psychosocial Impact and Disease Management in Patients with Congenital Factor VII Deficiency
Skye Peltier, Angela Kellum, Janet Brewer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 1, 2021
Impact of haemophilia on patients with mild-to-moderate disease: Results from the P-FiQ and B-HERO-S studies
Michelle Witkop, Michael Wang, Grace Hernandez, et al.
Journal of Blood Medicine
|
December 5, 2018
Phenotypical variability in congenital FVII deficiency follows the ISTH-SSC severity classification guidelines: a review with illustrative examples from the clinic
Shilpa Jain, Jennifer Donkin, Mary-Jane Frey, et al.
Patient Preference and Adherence
|
October 26, 2017
Known-group validity of patient-reported outcome instruments and hemophilia joint health score v2.1 in US adults with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study
Tyler W Buckner, Michael Wang, David L Cooper, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 102) with videos related to
Sort By:
Page
of 11
Angewandte Chemie (International Ed. in English)
|
October 31, 2002
Silynes (RC identical with SiR') and Disilynes (RSi identical with SiR'): Why Are Less Bonds Worth Energetically More? The research is supported by an Israel Science Foundation (ISF) and a Niedersachsen grant (to S.S.), by a U.S.-Israel Binational Science Foundation (BSF) grant (to Y.A.) and by the Minerva Foundation. S.S. and F.O. thank the European Union for a Marie Curie Fellowship (Contract number: MCFI-1999-00145). S.S. and D.D. thank P. C. Hiberty for the helpful advice
David Danovich, François Ogliaro, Miriam Karni, et al.
Research and Practice in Thrombosis and Haemostasis
|
September 1, 2020
Hemophilia without prophylaxis: Assessment of joint range of motion and factor activity
Michael Wang, Michael Recht, Neeraj N Iyer, et al.
Angewandte Chemie (International Ed. in English)
|
May 2, 2018
Silynes (RC≡SiR') and Disilynes (RSi≡SiR'): Why Are Less Bonds Worth Energetically More?
David Danovich, François Ogliaro, Miriam Karni, et al.
Pediatric Blood & Cancer
|
May 28, 2016
Safety and efficacy of recombinant factor VIIa by pediatric age cohort: reassessment of compassionate use and trial data supporting US label
Stacy E Croteau, Charles Nakar, Ellis J Neufeld, et al.
Patient Preference and Adherence
|
September 2, 2017
Construct validity of patient-reported outcome instruments in US adults with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study
Katharine Batt, Michael Recht, David L Cooper, et al.
Patient Related Outcome Measures
|
September 10, 2019
Mild-severe hemophilia B impacts relationships of US adults and children with hemophilia B and their families: results from the B-HERO-S study
Susan Cutter, Christine Guelcher, Susan Hunter, et al.
Journal of Blood Medicine
|
September 28, 2020
Psychosocial Impact and Disease Management in Patients with Congenital Factor VII Deficiency
Skye Peltier, Angela Kellum, Janet Brewer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 1, 2021
Impact of haemophilia on patients with mild-to-moderate disease: Results from the P-FiQ and B-HERO-S studies
Michelle Witkop, Michael Wang, Grace Hernandez, et al.
Journal of Blood Medicine
|
December 5, 2018
Phenotypical variability in congenital FVII deficiency follows the ISTH-SSC severity classification guidelines: a review with illustrative examples from the clinic
Shilpa Jain, Jennifer Donkin, Mary-Jane Frey, et al.
Patient Preference and Adherence
|
October 26, 2017
Known-group validity of patient-reported outcome instruments and hemophilia joint health score v2.1 in US adults with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study
Tyler W Buckner, Michael Wang, David L Cooper, et al.
Page
of 11